Article Text

Download PDFPDF
High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Informed consent was obtained for publication of the patient’s details described in this report.

    Ethical approval: Ethics committee approval was secured for the study reported by the Stichting Slotervaartziekenhuis, Medisch Ethische Toetsingscommissie, Amsterdam.